ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.

ICVX Icosavax Inc

15,31
0,00 (0,00%)
03 Mai 2024 - Geschlossen
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Icosavax Inc ICVX NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
0,00 0,00% 15,31 02:00:00
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
15,31 15,31
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
01.3.202414:30EDGAR2Form 15-12G - Securities registration termination [Section..
21.2.202422:21EDGAR2Form SC 13D/A - General statement of acquisition of..
21.2.202406:15EDGAR2Form EFFECT - Notice of Effectiveness
21.2.202401:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21.2.202401:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21.2.202401:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21.2.202401:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21.2.202401:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21.2.202401:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21.2.202401:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20.2.202414:46EDGAR2Form S-8 POS - Securities to be offered to employees in..
20.2.202414:43EDGAR2Form POS AM - Post-Effective amendments for registration..
20.2.202414:42EDGAR2Form 8-K - Current report
20.2.202414:32EDGAR2Form SC 14D9/A - Solicitation, recommendation statements:..
03.2.202401:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01.2.202420:25PRNUSKuehn Law Encourages ICVX, CSTR, AVRO, and CALB Investors to..
24.1.202400:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19.1.202415:04EDGAR2Form SC 14D9/A - Solicitation, recommendation statements:..
12.1.202417:10PRNUSKuehn Law Encourages PXD, IMGN, HA and ICVX Investors to..
06.1.202401:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04.1.202423:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04.1.202422:52EDGAR2Form 144 - Report of proposed sale of securities
03.1.202420:57PRNUSKuehn Law Encourages EGLE, ICVX, RAIN, and AYX Investors to..
27.12.202314:55EDGAR2Form SC 14D9 - Solicitation, recommendation statements
23.12.202300:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23.12.202300:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23.12.202300:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23.12.202300:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21.12.202322:42EDGAR2Form 144 - Report of proposed sale of securities
21.12.202322:28EDGAR2Form 144 - Report of proposed sale of securities
21.12.202302:54EDGAR2Form 144 - Report of proposed sale of securities
21.12.202302:50EDGAR2Form 144 - Report of proposed sale of securities
21.12.202302:50EDGAR2Form 144 - Report of proposed sale of securities
21.12.202302:44EDGAR2Form 144 - Report of proposed sale of securities
20.12.202323:05EDGAR2Form SC14D9C - Written communication relating to third party..
20.12.202322:41EDGAR2Form 144 - Report of proposed sale of securities
16.12.202301:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14.12.202322:18EDGAR2Form SC14D9C - Written communication relating to third party..
13.12.202322:26EDGAR2Form 144 - Report of proposed sale of securities
12.12.202323:00EDGAR2Form SC14D9C - Written communication relating to third party..
12.12.202322:56EDGAR2Form SC14D9C - Written communication relating to third party..
12.12.202322:12EDGAR2Form 8-K - Current report
12.12.202312:25DJNIcosavax Shares Take Flight on Takeover by AstraZeneca
12.12.202309:02DJNAstraZeneca to Buy Icosavax for Up to $1.1 Billion -- Update
12.12.202308:47DJNAstraZeneca to Buy Icosavax for Up to $1.1 Billion
12.12.202308:05GLOBEIcosavax, Inc. Announces Agreement to be Acquired by..
12.12.202308:00GLOBEIcosavax Announces Positive Topline Interim Phase 2 Results..
14.11.202322:05GLOBEIcosavax Reports Third Quarter 2023 Financial Results and..
08.11.202314:00GLOBEIcosavax to Participate in the Jefferies London Healthcare..
31.10.202313:00GLOBEIcosavax to Participate in the Guggenheim Healthcare Talks..

Kürzlich von Ihnen besucht

Delayed Upgrade Clock